Article Text
PDF
Abstract
Autogenous staphylococcal bacterins are commonly mentioned as treatment for canine recurrent pyoderma but little is known about their efficacy. This retrospective study describes use and assesses efficacy of an autogenous Staphylococcus (pseud)intermedius bacterin in dogs with pyoderma. Frequency and duration of systemic antimicrobial therapy were compared 12 months before and after starting bacterin (Wilcoxon signed-rank test) with data extracted from general practice medical histories.
- bacterial diseases
- dermatology
- antimicrobials
- dogs
Statistics from Altmetric.com
Supplementary data
Footnotes
Funding Self-funded.
Competing interests None declared.
Ethics approval The study had been approved by the Royal Veterinary College (RVC) Ethics and Welfare Committee (URN 2014 1294).
Provenance and peer review Not commissioned; externally peer reviewed.
Request Permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.